Welcome, friends!

If you’re obsessed with health-tech, this is the newsletter for you!

I’ll draw on a decade of experience covering the industry as a reporter at CNBC, Fast Company and Reuters - and now as an investor at OMERS Ventures - to share my unfiltered thoughts with you. During my tenure as a reporter, I broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. I also appeared on air (that’s me, below right) to chat about the biggest digital health news of the moment.

My style is to be a truth teller. I will do my best to sift through the noise and help you navigate what’s really going on in health-tech. I welcome feedback, positive or negative, so please reach out to me.

Why subscribe?

Second Opinion will feature analysis and interviews with founders, executives, investors and operators on the future of health care. The goal is to leverage my network to get into the context (in journalism, we call it the “so what”) behind the news of the moment. My solemn promise is to do this without bombarding your inbox.

Join the crew

If there’s a topic I should be writing about, reach out on Twitter at @chrissyfarr.

Subscribe to Second Opinion

Insights on the latest health-technology news and trends. Author Christina Farr leads with real talk, nuance and authenticity. Join a community of 20,000 professionals and subscribe today.


Founder turned VC at OMERSventures (previously Balderton Capital). Early investor in Revolut, Paddle, Touch Surgery, GoCardless, Gousto etc. Pianist. Psychologist. Optimist.